Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Colcher

Showing results (61-70 of 140) with videos related to

Pageof 14
Sort By:
Cancer Research|February 1, 1986
Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3V G Johnson, J Schlom, A J Paterson, et al.
International Journal of Cancer|May 15, 1982
A monoclonal antibody (B72.3) defines patterns of distribution of a novel tumor-associated antigen in human mammary carcinoma cell populationsM Nuti, Y A Teramoto, R Mariani-Costantini, et al.
Journal of Clinical Laboratory Analysis|January 1, 1989
CA 72-4 radioimmunoassay for the detection of the TAG-72 carcinoma-associated antigen in serum of patientsE J Gero, D Colcher, P Ferroni, et al.
Hybridoma|April 1, 1997
Clinical and immunologic effects of monoclonal antibody CC49 and interleukin-2 in patients with metastatic colorectal cancerP L Triozzi, J A Kim, E W Martin, et al.
The American Journal of Surgical Pathology|January 1, 1989
Co-expression of CA 19-9, DU-PAN-2, CA 125, and TAG-72 in pancreatic adenocarcinomaM Tempero, H Takasaki, E Uchida, et al.
Laboratory and Research Methods in Biology and Medicine|January 1, 1983
Monoclonal antibodies to human mammary carcinoma associated antigens and their potential uses for diagnosis, prognosis, and therapyD Colcher, P H Hand, D Wunderlich, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
Potential artifact for the increase of tumor associated antigens in serum samples from patients injected with monoclonal antibodiesP Ferroni, D E Milenic, M Roselli, et al.
The International Journal of Biological Markers|October 1, 1990
Potential for artifacts in monitoring for the detection of tumor associated antigens (TAG-72 and CEA) in serum from patients undergoing MAb-based diagnostic and therapeutic protocolsP Ferroni, D E Milenic, M Roselli, et al.
Science (New York, N.Y.)|February 20, 1987
Recombinant interferon enhances monoclonal antibody-targeting of carcinoma lesions in vivoJ W Greiner, F Guadagni, P Noguchi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1989
Comparative biodistributions of yttrium- and indium-labeled monoclonal antibody B72.3 in athymic mice bearing human colon carcinoma xenograftsM Roselli, J Schlom, O A Gansow, et al.
Pageof 14

Showing results (61-70 of 140) with videos related to

Sort By:
Pageof 14
Cancer Research|February 1, 1986
Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3V G Johnson, J Schlom, A J Paterson, et al.
International Journal of Cancer|May 15, 1982
A monoclonal antibody (B72.3) defines patterns of distribution of a novel tumor-associated antigen in human mammary carcinoma cell populationsM Nuti, Y A Teramoto, R Mariani-Costantini, et al.
Journal of Clinical Laboratory Analysis|January 1, 1989
CA 72-4 radioimmunoassay for the detection of the TAG-72 carcinoma-associated antigen in serum of patientsE J Gero, D Colcher, P Ferroni, et al.
Hybridoma|April 1, 1997
Clinical and immunologic effects of monoclonal antibody CC49 and interleukin-2 in patients with metastatic colorectal cancerP L Triozzi, J A Kim, E W Martin, et al.
The American Journal of Surgical Pathology|January 1, 1989
Co-expression of CA 19-9, DU-PAN-2, CA 125, and TAG-72 in pancreatic adenocarcinomaM Tempero, H Takasaki, E Uchida, et al.
Laboratory and Research Methods in Biology and Medicine|January 1, 1983
Monoclonal antibodies to human mammary carcinoma associated antigens and their potential uses for diagnosis, prognosis, and therapyD Colcher, P H Hand, D Wunderlich, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
Potential artifact for the increase of tumor associated antigens in serum samples from patients injected with monoclonal antibodiesP Ferroni, D E Milenic, M Roselli, et al.
The International Journal of Biological Markers|October 1, 1990
Potential for artifacts in monitoring for the detection of tumor associated antigens (TAG-72 and CEA) in serum from patients undergoing MAb-based diagnostic and therapeutic protocolsP Ferroni, D E Milenic, M Roselli, et al.
Science (New York, N.Y.)|February 20, 1987
Recombinant interferon enhances monoclonal antibody-targeting of carcinoma lesions in vivoJ W Greiner, F Guadagni, P Noguchi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1989
Comparative biodistributions of yttrium- and indium-labeled monoclonal antibody B72.3 in athymic mice bearing human colon carcinoma xenograftsM Roselli, J Schlom, O A Gansow, et al.
Pageof 14